Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas

Aaron M Bender1, Lara S Collier, Fausto J Rodriguez

  • 1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.

Cancer Research
|April 15, 2010
PubMed

Insights

The Sleeping Beauty (SB) transposon system identified the growth factor gene Csf1 as a potential driver of high-grade astrocytomas. This finding highlights CSF1

Area of Science:

  • Genetics
  • Oncology
  • Neuroscience

Background:

  • The Sleeping Beauty (SB) transposon system is a powerful tool for insertional mutagenesis.
  • Identifying genes driving glioma development is crucial for understanding and treating brain tumors.

Purpose of the Study:

  • To identify novel genes associated with glioma development using SB-mediated transposition.
  • To investigate the role of identified genes in high-grade astrocytoma formation.

Main Methods:

  • Utilized SB-mediated transposition in 117 transgenic mice to induce tumor formation.
  • Analyzed tumor tissue for neoplastic changes and characterized transposon insertion sites.
  • Employed reverse transcription-PCR to quantify Csf1 RNA levels in tumor and normal tissues.

Main Results:

  • 18% of mice developed high-grade astrocytomas similar to human glioma.
  • Insertions in the Csf1 gene were found in 62% of tumors, specifically in introns 5 and 8.
  • Elevated Csf1 RNA and protein levels were observed in both mouse and human glioblastomas.

Conclusions:

  • SB-insertional mutagenesis is effective in identifying high-grade astrocytoma-associated genes.
  • The growth factor gene Csf1 plays a significant role in the development of these brain tumors.

Related Concept Videos